ロード中...
Review of extended-release niacin/laropiprant fixed combination in the treatment of mixed dyslipidemia and primary hypercholesterolemia
Although statins reduce cardiovascular morbidity and mortality further risk reduction is needed. In this respect low HDL-cholesterol concentrations and/or elevated triglyceride concentrations may be potential treatment targets. Niacin (nicotinic acid) is an effective drug which increases the plasma...
保存先:
| フォーマット: | 論文 |
|---|---|
| 言語: | en |
| 出版事項: |
Dove Medical Press
2009
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2788595/ https://ncbi.nlm.nih.gov/pubmed/20016845 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|